The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Acute-on-chronic liver failure: Definitions, pathophysiology and principles of treatment
Open accessAbstract
The term acute-on-chronic liver failure (ACLF) defines an abrupt and life-threatening worsening of clinical conditions in patients with cirrhosis or chronic liver disease. In recent years, different definitions and diagnostic criteria for the syndrome have been proposed by the major international scientific societies. The main controversies relate to the type of acute insult (specifically hepatic or also extrahepatic), the stage of underlying liver disease (cirrhosis or chronic hepatitis) and the concomitant extrahepatic organ failure(s) that should be considered in the definition of ACLF. Therefore, different severity criteria and prognostic scores have been proposed and validated. Current evidence shows that the pathophysiology of ACLF is closely associated with an intense systemic inflammation sustained by circulating pathogen-associated molecular patterns and damage-associated molecular patterns. The development of organ failures may be a result of a combination of tissue hypoperfusion, direct immune-mediated damage and mitochondrial dysfunction. Management of ACLF is currently based on the supportive treatment of organ failures, mainly in an intensive care setting. For selected patients, liver transplantation is an effective treatment that offers a good long-term prognosis. Future studies on potential mechanistic treatments that improve patient survival are eagerly awaited.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Origin and physiological roles of inflammation
Medzhitov, R. (2008) · Nature · doi:10.1038/nature07201 · Cited by 6,618
DAMPs, PAMPs and alarmins: all we need to know about danger
Bianchi, M. E. (2007) · Journal of Leukocyte Biology · doi:10.1189/jlb.0306164 · Cited by 2,794
Control of adaptive immunity by the innate immune system
Iwasaki, A., & Medzhitov, R. (2015) · Nature Immunology · doi:10.1038/ni.3123 · Cited by 2,160 · cited 2×
“Of note, bacterial virulence factors can induce inflammation, not through their direct recognition by PRRs but through functional effects they induce in cells; for example, pore-forming toxins induce a K efflux through the cell membrane that contributes to the activation of the NLRP3 (NLR family pyrin domain containin…”
BackgroundSarin, S. K., Kedarisetty, C. K., Abbas, Z., Amarapurkar, D., Bihari, C., Chan, A. C. Y., Chawla, Y. K., Dokmeci, A. K., Garg, H., Ghazinyan, H., et al. (2014) · Hepatology International · doi:10.1007/s12072-014-9580-2 · Cited by 1,481
Self-citationWu, T., Li, J., Shao, L., Xin, J., Jiang, L., Zhou, Q., Shi, D., Jiang, J., Sun, S., Jin, L., et al. (2018) · Gut · doi:10.1136/gutjnl-2017-314641 · Cited by 437
Bernsmeier, C., Pop, O. T., Singanayagam, A., Triantafyllou, E., Patel, V. C., Weston, C. J., Curbishley, S., Sadiq, F., Vergis, N., Khamri, W., et al. (2015) · Gastroenterology · doi:10.1053/j.gastro.2014.11.045 · Cited by 287
Bernsmeier, C., Triantafyllou, E., Brenig, R., Lebosse, F. J., Singanayagam, A., Patel, V. C., Pop, O. T., Khamri, W., Nathwani, R., Tidswell, R., et al. (2018) · Gut · doi:10.1136/gutjnl-2017-314184 · Cited by 159
Research works printed but not linked: 71
- Arroyo, 2020, Acute-on-chronic liver failure, N Engl J Med, 382, 2137, 10.1056/NEJMra1914900 · DOI · Paper page
- Moreau, 2013, Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis, Gastroenterology, 144, 1426, 10.1053/j.gastro.2013.02.042 · DOI · Paper page
- Bajaj, 2014, Survival in infection-related acute-on-chronic liver failure is defined by extrahepatic organ failures, Hepatology, 60, 250, 10.1002/hep.27077 · DOI · Paper page
- Sarin, 2019, Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific Association for the Study of the Liver (APASL): an update, Hepatol Int, 13, 353, 10.1007/s12072-019-09946-3 · DOI · Paper page
- Sarin, 2009, Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific Association for the Study of the Liver (APASL), Hepatol Int, 3, 269, 10.1007/s12072-008-9106-x · DOI · Paper page
- Jalan, 2014, Development and validation of a prognostic score to predict mortality in patients with acute-on-chronic liver failure, J Hepatol, 61, 1038, 10.1016/j.jhep.2014.06.012 · DOI · Paper page
- O'Leary, 2018, NACSELD acute-on-chronic liver failure (NACSELD-ACLF) score predicts 30-day survival in hospitalized patients with cirrhosis, Hepatology, 67, 2367, 10.1002/hep.29773 · DOI · Paper page
- Fernández, 2018, Bacterial and fungal infections in acute-on-chronic liver failure: prevalence, characteristics and impact on prognosis, Gut, 67, 1870, 10.1136/gutjnl-2017-314240 · DOI · Paper page
- Mahmud, 2019, Incidence and mortality of acute-on-chronic liver failure using two definitions in patients with compensated cirrhosis, Hepatology, 69, 2150, 10.1002/hep.30494 · DOI · Paper page
- Piano, 2017, Incidence, predictors and outcomes of acute-on-chronic liver failure in outpatients with cirrhosis, J Hepatol, 67, 1177, 10.1016/j.jhep.2017.07.008 · DOI
- Sundaram, 2018, Class III obesity is a risk factor for the development of acute-on-chronic liver failure in patients with decompensated cirrhosis, J Hepatol, 69, 617, 10.1016/j.jhep.2018.04.016 · DOI
- Gustot, 2015, Clinical Course of acute-on-chronic liver failure syndrome and effects on prognosis, Hepatology, 62, 243, 10.1002/hep.27849 · DOI · Paper page
- Li, 2016, Characteristics, diagnosis and prognosis of acute-on-chronic liver failure in cirrhosis associated to hepatitis B, Sci Rep, 6, 25487, 10.1038/srep25487 · DOI · Paper page
- Kim, 2016, Characteristics and discrepancies in acute-on-chronic liver failure: need for a unified definition, PLoS One, 11, e0146745, 10.1371/journal.pone.0146745 · DOI
- Hernaez, 2019, Prevalence and short-term mortality of acute-on-chronic liver failure: a national cohort study from the USA, J Hepatol, 70, 639, 10.1016/j.jhep.2018.12.018 · DOI
- Amarapurkar, 2015, Acute-on-chronic liver failure: a prospective study to determine the clinical profile, outcome, and factors predicting mortality, Indian J Gastroenterol, 34, 216, 10.1007/s12664-015-0574-3 · DOI
- Shi, 2015, Acute-on-chronic liver failure precipitated by hepatic injury is distinct from that precipitated by extrahepatic insults, Hepatology, 62, 232, 10.1002/hep.27795 · DOI · Paper page
- Abbas, 2015, Pattern and profile of chronic liver disease in acute on chronic liver failure, Hepatol Int, 9, 366, 10.1007/s12072-015-9627-z · DOI
- Chen, 2019, Complications constitute a major risk factor for mortality in hepatitis B virus-related acute-on-chronic liver failure patients: a multi-national study from the Asia-Pacific region, Hepatol Int, 13, 695, 10.1007/s12072-019-09992-x · DOI
- Karvellas, 2018, Dynamic prognostication in critically ill cirrhotic patients with multiorgan failure in ICUs in Europe and North America: a multicenter analysis, Crit Care Med, 46, 1783, 10.1097/CCM.0000000000003369 · DOI · Paper page
- Clària, 2016, Systemic inflammation in decompensated cirrhosis. Characterization and role in acute-on-chronic liver failure, Hepatology, 64, 1249, 10.1002/hep.28740 · DOI · Paper page
- Bernardi, 2015, Mechanisms of decompensation and organ failure in cirrhosis: from peripheral arterial vasodilation to systemic inflammation hypothesis, J Hepatol, 63, 1272, 10.1016/j.jhep.2015.07.004 · DOI · Paper page
- Moreau, 2018, Effects of long-term norfloxacin therapy in patients with advanced cirrhosis, Gastroenterology, 155, 1816, 10.1053/j.gastro.2018.08.026 · DOI · Paper page
- Wiest, 2014, Pathological bacterial translocation in liver cirrhosis, J Hepatol, 60, 197, 10.1016/j.jhep.2013.07.044 · DOI · Paper page
- Petrasek, 2013, STING-IRF3 pathway links endoplasmic reticulum stress with hepatocyte apoptosis in early alcoholic liver disease, Proc Natl Acad Sci USA, 110, 16544, 10.1073/pnas.1308331110 · DOI · Paper page
- Evankovich, 2010, High mobility group box 1 release from hepatocytes during ischemia and reperfusion injury is mediated by decreased histone deacetylase activity, J Biol Chem, 285, 39888, 10.1074/jbc.M110.128348 · DOI · Paper page
- Li, 2015, Submassive hepatic necrosis distinguishes HBV-associated acute on chronic liver failure from cirrhotic patients with acute decompensation, J Hepatol, 63, 50, 10.1016/j.jhep.2015.01.029 · DOI
- Bortoluzzi, 2013, Positive cardiac inotropic effect of albumin infusion in rodents with cirrhosis and ascites: molecular mechanisms, Hepatology, 57, 266, 10.1002/hep.26021 · DOI
- Rodríguez-Roisin, 2008, Hepatopulmonary syndrome - a liver-induced lung vascular disorder, N Engl J Med, 358, 2378, 10.1056/NEJMra0707185 · DOI · Paper page
- Gustot, 2009, Severe sepsis in cirrhosis, Hepatology, 50, 2022, 10.1002/hep.23264 · DOI · Paper page
- Alobaidi, 2015, Sepsis-associated acute kidney injury, Semin Nephrol, 35, 2, 10.1016/j.semnephrol.2015.01.002 · DOI · Paper page
- Moreau, 2020, Blood metabolomics uncovers inflammation-associated mitochondrial dysfunction as a potential mechanism underlying ACLF, J Hepatol, 72, 688, 10.1016/j.jhep.2019.11.009 · DOI · Paper page
- Bajaj, 2018, Prediction of fungal infection development and their impact on survival using the NACSELD cohort, Am J Gastroenterol, 113, 556, 10.1038/ajg.2017.471 · DOI
- Li, 2020, Clinical characteristics and 28-d outcomes of bacterial infections in patients with hepatitis B virus-related acute-on-chronic liver failure, World J Clin Cases, 8, 1042, 10.12998/wjcc.v8.i6.1042 · DOI
- Su, 2020, Characteristics and outcome of nosocomial bloodstream infection in patients with acute-on-chronic liver failure, Eur J Gastroenterol Hepatol
- Cai, 2017, Characteristics of infection and its impact on short-term outcome in patients with acute-on-chronic liver failure, Medicine (Baltimore), 96, e8057, 10.1097/MD.0000000000008057 · DOI
- Clària, 2019, Orchestration of tryptophan-kynurenine pathway, acute decompensation, and acute-on-chronic liver failure in cirrhosis, Hepatology, 69, 1686, 10.1002/hep.30363 · DOI
- Weichselbaum, 2020, Epigenetic basis for monocyte dysfunction in patients with severe alcoholic hepatitis, J Hepatol, 73, 303, 10.1016/j.jhep.2020.02.017 · DOI
- Rolas, 2018, NADPH oxidase depletion in neutrophils from patients with cirrhosis and restoration via toll-like receptor 7/8 activation, Gut, 67, 1505, 10.1136/gutjnl-2016-313443 · DOI
- McPhail, 2018, Incidence and outcomes for patients with cirrhosis admitted to the United Kingdom critical care units, Crit Care Med, 46, 705, 10.1097/CCM.0000000000002961 · DOI
- Galbois, 2014, Improved prognosis of septic shock in patients with cirrhosis: a multicenter study, Crit Care Med, 42, 1666, 10.1097/CCM.0000000000000321 · DOI
- Karvellas, 2014, Advances in management and prognostication in critically ill cirrhotic patients, Curr Opin Crit Care, 20, 210
- Weil, 2017, Prognosis of cirrhotic patients admitted to intensive care unit: a meta-analysis, Ann Intensive Care, 7, 33, 10.1186/s13613-017-0249-6 · DOI
- Piano, 2019, Epidemiology and effects of bacterial infections in patients with cirrhosis worldwide, Gastroenterology, 156, 1368, 10.1053/j.gastro.2018.12.005 · DOI · Paper page
- 2018, EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis, J Hepatol, 69, 406, 10.1016/j.jhep.2018.03.024 · DOI · Paper page
- Gustot, 2019, Acute-on-chronic liver failure in patients with alcohol-related liver disease, J Hepatol, 70, 319, 10.1016/j.jhep.2018.12.008 · DOI
- Sersté, 2018, The prognostic value of acute-on-chronic liver failure during the course of severe alcoholic hepatitis, J Hepatol, 69, 318, 10.1016/j.jhep.2018.02.022 · DOI
- Forrest, 2018, Prevalent acute-on-chronic liver failure and response to corticosteroids in alcoholic hepatitis, J Hepatol, 69, 1200, 10.1016/j.jhep.2018.06.019 · DOI
- Trebicka, 2020, Rebleeding and mortality risk are increased by ACLF but reduced by pre-emptive TIPS, J Hepatol, 73, 1082, 10.1016/j.jhep.2020.04.024 · DOI · Paper page
- Bernardi, 2020, Albumin in decompensated cirrhosis: new concepts and perspectives, Gut, 69, 1127, 10.1136/gutjnl-2019-318843 · DOI · Paper page
- Fernández, 2019, Effects of albumin treatment on systemic and portal hemodynamics and systemic inflammation in patients with decompensated cirrhosis, Gastroenterology, 157, 149, 10.1053/j.gastro.2019.03.021 · DOI · Paper page
- Arroyo, 2014, Human serum albumin, systemic inflammation, and cirrhosis, J Hepatol, 61, 396, 10.1016/j.jhep.2014.04.012 · DOI · Paper page
- O'Brien, 2014, Immunosuppression in acutely decompensated cirrhosis is mediated by prostaglandin E2, Nat Med, 20, 518, 10.1038/nm.3516 · DOI · Paper page
- Paugam-Burtz, 2020, Management of liver failure in general intensive care unit, Anaesth Crit Care Pain Med, 39, 143
- Fernández, 2020, Efficacy of albumin treatment for patients with cirrhosis and infections unrelated to spontaneous bacterial peritonitis, Clin Gastroenterol Hepatol, 18, 963, 10.1016/j.cgh.2019.07.055 · DOI
- Gaudry, 2020, Delayed vs. early initiation of renal replacement therapy for severe acute kidney injury: a systematic review and individual patient data meta-analysis of randomised clinical trials, Lancet, 395, 1506, 10.1016/S0140-6736(20)30531-6 · DOI · Paper page
- Zhang, 2015, Role of renal replacement therapy in patients with type 1 hepatorenal syndrome receiving combination treatment of vasoconstrictor plus albumin, J Crit Care, 30, 969, 10.1016/j.jcrc.2015.05.006 · DOI
- Karvellas, 2019, Intraoperative continuous renal replacement therapy during liver transplantation: a pilot randomized-controlled trial (INCEPTION), Can J Anaesth, 66, 1151, 10.1007/s12630-019-01454-0 · doi:10.1007/s12630-019-01454-0
- Bañares, 2013, Extracorporeal albumin dialysis with the molecular adsorbent recirculating system in acute-on-chronic liver failure: the RELIEF trial, Hepatology, 57, 1153, 10.1002/hep.26185 · DOI · Paper page
- Kribben, 2012, Effects of fractionated plasma separation and adsorption on survival in patients with acute-on-chronic liver failure, Gastroenterology, 142, 782, 10.1053/j.gastro.2011.12.056 · DOI · Paper page
- Gerth, 2017, Molecular adsorbent recirculating system can reduce short-term mortality among patients with acute-on-chronic liver failure - a retrospective analysis, Crit Care Med, 45, 1616, 10.1097/CCM.0000000000002562 · DOI
- Shen, 2016, Survival benefits with artificial liver support system for acute-on-chronic liver failure: a time series-based meta-analysis, Medicine (Baltimore), 95, e2506, 10.1097/MD.0000000000002506 · DOI
- Smets, 2019, Transplantation, 103, 1903, 10.1097/TP.0000000000002605 · DOI
- Sundaram, 2019, Factors associated with survival of patients with severe acute-on-chronic liver failure before and after liver transplantation, Gastroenterology, 156, 1381, 10.1053/j.gastro.2018.12.007 · DOI · Paper page
- Levesque, 2017, Impact of acute-on-chronic liver failure on 90-day mortality following a first liver transplantation, Liver Int, 37, 684, 10.1111/liv.13355 · DOI · Paper page
- Artru, 2017, Liver transplantation in the most severely ill cirrhotic patients: a multicenter study in acute-on-chronic liver failure grade 3, J Hepatol, 67, 708, 10.1016/j.jhep.2017.06.009 · DOI · Paper page
- Arroyo, 2019, Acute-on-chronic liver failure in cirrhosis requires expedited decisions for liver transplantation, Gastroenterology, 156, 1248, 10.1053/j.gastro.2019.03.004 · doi:10.1053/j.gastro.2019.03.004
- Hernaez, 2020, Model for end-stage liver disease-sodium underestimates 90-day mortality risk in patients with acute-on-chronic liver failure, J Hepatol
- Sundaram, 2019, Patients with acute on chronic liver failure grade 3 have greater 14-day waitlist mortality than status-1a patients, Hepatology, 70, 334, 10.1002/hep.30624 · DOI
- Weiss, 2020, When is a critically ill cirrhotic patient too sick to transplant? Development of consensus criteria by a multidisciplinary panel of 35 international experts, Transplantation
- Artzner, 2020, Liver transplantation for critically ill cirrhotic patients: stratifying utility based on pretransplant factors, Am J Transplant, 20, 2437, 10.1111/ajt.15852 · DOI
Cited by
EASL Clinical Practice Guidelines on acute-on-chronic liver failure
Moreau, R., Tonon, M., Krag, A., Angeli, P., Berenguer, M., Berzigotti, A., Fernandez, J., Francoz, C., Gustot, T., Jalan, R., et al. (2023) · Journal of Hepatology · doi:10.1016/j.jhep.2023.04.021 · Cited by 375
Self-citationAcute-on-chronic liver failure: far to go—a review
Luo, J., Li, J., Li, P., Liang, X., Hassan, H. M., Moreau, R., & Li, J. (2023) · Critical Care · doi:10.1186/s13054-023-04540-4 · Cited by 54
Self-citationLi, G., He, J., Shi, J., Li, X., Liu, L., Ge, X., Chen, W., Jia, J., Wang, J., Yin, M., et al. (2025) · Gut · doi:10.1136/gutjnl-2024-333885 · Cited by 41
Metadata
- Authors
- Zaccherini, G., Weiss, E., & Moreau, R.
- Venue
- JHEP Reports
- Publisher
- Elsevier BV
- Published
- 2021-02
- Volume
- 3
- Issue
- 1
- Pages
- 100176
- ISSN
- 2589-5559 (ISSN-L)
- OpenAlex
- W3082738002
- Cited by
- 204
- References
- 7
- FWCI
- 12.43
- Type
- journal article
- Language
- en
- Open access
- gold
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- creativecommons.org/licenses/by-nc-nd/4.0/ (vor)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.